InMode Defends Its Feminine Rejuvenation Patent Against BTL Industries' Review Request
Portfolio Pulse from Benzinga Newsdesk
InMode Ltd. (NASDAQ:INMD) is defending its U.S. Patent No. 8,961,511 on feminine rejuvenation technology against a review request by BTL Industries to the USPTO. This follows InMode's lawsuit against BTL for allegedly infringing this patent with their UltraFemme 360 and EmFemme 360 products. The legal battle is ongoing in the United States District Court for the Central District of California.
April 15, 2024 | 11:08 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
InMode Ltd. is actively defending its patent related to feminine rejuvenation technology against BTL Industries, which could impact its market position and financial health depending on the outcome.
The ongoing legal battle and patent defense are crucial for InMode as they protect the company's intellectual property and market share in the feminine rejuvenation sector. However, the outcome is uncertain, and legal disputes can have varying impacts on a company's stock price, depending on developments and investor perceptions.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90